Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Appalaraju Jaggupilli(University of Salford), Eyad Elkord(Hamad bin Khalifa University)
Cited by 498
Related Papers
Immune checkpoint inhibitors: recent progress and potential biomarkers
|Experimental & Molecular Medicine|2018|2.1k
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
|Frontiers in Immunology|2019|155
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
|Oncotarget|2017|124